AzTrials
AzTrials

Children at Risk for ASDBabyJNCT01874327

Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)

A study testing Baby JASPER and Standard Baby Classroom in people with Children at Risk for ASD, run by University of California, Los Angeles at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder. Read more about this study

Who is it for?
Ages 12 to 21 months
Conditions the study is for
Children at Risk for ASD
What is being tested?
Baby JASPER and Standard Baby Classroom
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteUnited States
Study dates
Jan 2013to Sep 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 21 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Have elevated scores on the ADOS-Toddler version and clinical concern from professional (Pediatrician, Psychologist, etc). Because of the young age of children, we expect to intervene with children who do not yet have a diagnosis of ASD but may only show some risk by virtue of elevated scores on the ADOS-T.
  • Have a parent available for parent-mediated sessions 2 times per week in the classroom
  • Do not have seizures
  • Do not have associated sensory or physical disorders
  • Are not co-morbid with other syndromes or diseases

Who cannot join

  • Other co-morbid syndromes or diseases
  • Seizure activity
  • Other sensory or physical disorders

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCLA Semel Institue

    Los Angeles, California, 90024

Other trials in United States

About this study

Official title: Joint Engagement in Infants at Risk for ASD: Integrating Treatment With Biomarkers

The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.

Read the detailed description

The proposed intervention adapts a parent-mediated intervention that successfully improved outcomes in toddlers with autism. The intervention model (a) targets the foundations of social-communication (joint attention, imitation, play), (b) uses naturalistic strategies to increase the rate and complexity of social-communication and (c) includes parents as implementers of the intervention to promote generalization across settings and activities and to ensure maintenance over time.

In addition to testing the primary effects of this early intervention on the developmental outcomes of children with signs of autism, we will examine whether this method is superior to an early intervention focused on global infant development. Because brain development occurs rapidly in infants and toddlers, we will use high density EEG to investigate (1) biomarkers of change in these infants as a result of intervention and (2) biomarkers predicting response to treatment, with focus on the neural correlates of social attention and learning from joint engagement.

Study Aims:

AIM 1: To examine the effects of the experimental intervention (Baby JASPER) on primary (joint attention) and secondary outcomes (receptive language, play, symbol-infused joint engagement and parent use of social communication support strategies).

AIM 2: To examine maintenance and generalization of the effects of the experimental intervention on children and their parents.

AIM 3: To examine electrophysiological biomarkers of change with treatment as well as predictors of social communication outcomes in children after intervention.

AIM 4 (exploratory): To examine the effect of potential child level and parent level moderators on the primary and secondary outcomes of the study across the two conditions.

Being tested
Baby JASPER, Standard Baby Classroom

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Baby JASPERBehavioural

    Intervention focuses on core deficits of joint attention, play, engagement, and regulation embedded within AEPS curriculum

  • Standard Baby ClassroomBehavioural

    Assessment, Education and Programming System (AEPS) for Infants and Children curriculum focused on early developmental milestones in fine and gross motor, cognitive, adaptive and social areas

Study groups in NCT01874327
Study groupRoleWhat they receive
Baby JASPERActive comparatorThis classroom will spend the majority of the time focusing on social-communication goals
Receives: Behavioral: Baby JASPER
Standard Baby ClassroomActive comparatorThis classroom will focus more heavily on developing motor and cognitive skills
Receives: Behavioral: Standard Baby Classroom

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessing change in Parent Child Interaction (PCX) throughout the diverse time points.

    10 minute unstructured free play assessment with caregiver and child measuring change over the duration of the study.

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

Secondary outcomes (7)
  1. Autism Diagnostic Observation Schedule Toddler module (ADOS-T)

    Semi-structured, standardized assessment of communication, social interaction, play and imaginative use of materials

    Measured: Prior to treatment commencing (Study Entry) and 10 months post treatment exit

  2. Imitation Task

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

  3. Vineland Adaptive Behavior Scales (VABS)

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

  4. EEG/Event Related Potential (ERP)

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

  5. Mullen Scales of Early Learning (MSEL)

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

  6. Early Social Communication Scales (ESCS)

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

  7. Structured Play Assessment (SPA)

    Measured: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionAug 2018
  4. Study completionSep 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Care provider
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01874327
Sponsor's protocol ID
12-000607
Acronym
BabyJ
Status last verified
Oct 2018
First submitted
28 Oct 2012
Last updated
10 Oct 2018
Results posted
No
Data monitoring committee
No

Publications

  • Abidin, R. R. (1983). Parenting Stress Index manual. Charlottesville, VA: Pediatric Psychology Press.

  • Adamson LB, Bakeman R, Deckner DF. The development of symbol-infused joint engagement. Child Dev. 2004 Jul-Aug;75(4):1171-87. doi: 10.1111/j.1467-8624.2004.00732.x.

    PubMed 15260871
  • Akhtar N, Dunham F, Dunham PJ. Directive interactions and early vocabulary development: the role of joint attentional focus. J Child Lang. 1991 Feb;18(1):41-9. doi: 10.1017/s0305000900013283.

    PubMed 2010504
  • Arnold, S. D., Elliot, M., Storoschuk, S., Pickles, A., Hellriegel, C., & Lord, C. (1993) Social directedness and prelinguistic vocalization in autism. Paper presented at the meeting of the American Academy of Child and Adolescent Psychiatry, San Antonio, TX.

  • Bakeman R, Adamson LB. Coordinating attention to people and objects in mother-infant and peer-infant interaction. Child Dev. 1984 Aug;55(4):1278-89.

    PubMed 6488956
  • Barnes S, Gutfreund M, Satterly D, Wells G. Characteristics of adult speech which predict children's language development. J Child Lang. 1983 Feb;10(1):65-84. doi: 10.1017/s0305000900005146. No abstract available.

    PubMed 6841502
  • Baron-Cohen S. The autistic child's theory of mind: a case of specific developmental delay. J Child Psychol Psychiatry. 1989 Mar;30(2):285-97. doi: 10.1111/j.1469-7610.1989.tb00241.x.

    PubMed 2523408
  • Baron-Cohen, S. (1993). From attention-goal psychology to belief-desire psychology: The development of a theory of mind and its dysfunction. In S. Baron-Cohen, H. Tager-Flusberg, & D. J. Cohen (Eds.), Understanding other minds: Perspectives from autism, Oxford, UK: Oxford University Press.

  • Brereton, A., & Tonge, B. (2005). Pre-schoolers with autism: An education and skills training programme for parents. London, UK: Jessica Kingsley Publishers.

  • Brown, R. (1973). A first language: The early stages. Cambridge, MA: Harvard University Press.

  • Bruner, J.S. (1974/75). From communication to language: A psychological perspective. Cognition, 3, 255-287.

  • Bryk, A., & Raudenbush, S. (1992). Hierarchical linear models: Applications and data analysis methods. Newborn Park, CA: Sage.

  • Cross, T. G. (1977). Mother's speech adjustments: The contribution of selected child listener variables. In C. E. Snow and C. A. Ferguson (Eds.), Talking to children: Language input and acquisition. Cambridge: Cambridge University Press.

  • Curcio F. Sensorimotor functioning and communication in mute autistic children. J Autism Child Schizophr. 1978 Sep;8(3):281-92. doi: 10.1007/BF01539631.

    PubMed 690064
  • D'Amico EJ, Neilands TB, Zambarano R. Power analysis for multivariate and repeated measures designs: a flexible approach using the SPSS MANOVA procedure. Behav Res Methods Instrum Comput. 2001 Nov;33(4):479-84. doi: 10.3758/bf03195405.

    PubMed 11816450

Questions about this trial

What is this clinical trial studying?

A study testing Baby JASPER and Standard Baby Classroom in people with Children at Risk for ASD, run by University of California, Los Angeles at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessing change in Parent Child Interaction (PCX) throughout the diverse time points. (time frame: Prior to treatment commencing (Study Entry), within treatment (3 and 6 weeks post entry), Exit (8-10 weeks post entry), and three further follow ups (2 months post exit, 4 months post exit and 10 months post exit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01874327, which also lists 50 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in